Correlation Between Nurix Therapeutics and Seer
Can any of the company-specific risk be diversified away by investing in both Nurix Therapeutics and Seer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nurix Therapeutics and Seer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nurix Therapeutics and Seer Inc, you can compare the effects of market volatilities on Nurix Therapeutics and Seer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nurix Therapeutics with a short position of Seer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nurix Therapeutics and Seer.
Diversification Opportunities for Nurix Therapeutics and Seer
0.91 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Nurix and Seer is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and Seer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seer Inc and Nurix Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nurix Therapeutics are associated (or correlated) with Seer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seer Inc has no effect on the direction of Nurix Therapeutics i.e., Nurix Therapeutics and Seer go up and down completely randomly.
Pair Corralation between Nurix Therapeutics and Seer
Given the investment horizon of 90 days Nurix Therapeutics is expected to under-perform the Seer. In addition to that, Nurix Therapeutics is 1.8 times more volatile than Seer Inc. It trades about -0.17 of its total potential returns per unit of risk. Seer Inc is currently generating about -0.17 per unit of volatility. If you would invest 226.00 in Seer Inc on December 27, 2024 and sell it today you would lose (44.00) from holding Seer Inc or give up 19.47% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Nurix Therapeutics vs. Seer Inc
Performance |
Timeline |
Nurix Therapeutics |
Seer Inc |
Nurix Therapeutics and Seer Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nurix Therapeutics and Seer
The main advantage of trading using opposite Nurix Therapeutics and Seer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nurix Therapeutics position performs unexpectedly, Seer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seer will offset losses from the drop in Seer's long position.Nurix Therapeutics vs. Foghorn Therapeutics | Nurix Therapeutics vs. Shattuck Labs | Nurix Therapeutics vs. Monte Rosa Therapeutics | Nurix Therapeutics vs. Kymera Therapeutics |
Seer vs. Oric Pharmaceuticals | Seer vs. Anebulo Pharmaceuticals | Seer vs. Cullinan Oncology LLC | Seer vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |